Bigul

Neogen Chemicals Ltd - 542665 - Sub: Outcome Of Board Meeting Held On Saturday, May 13, 2023.

1. Approved the Audited Financial Results (Standalone and Consolidated) of the Company along with the Audit Reports for the Quarter and Financial Year ended March 31, 2023, pursuant to Regulation 33 of the Listing Regulations, which has been duly reviewed and recommended by the Audit Committee; Pursuant to Regulation 33(3) (d) of the Listing Regulations, we would like to declare that the Statutory Auditors of the Company M/s. JMT & Associates, Chartered Accountants (FRN: 104167W) have issued the Auditors Report on Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2023 with un-modified opinion and a declaration to that effect is enclosed. 2. Recommended a final dividend of Rs. 3 per Equity Share for the Financial Year 2022-23, subject to approval of shareholders at the ensuing Annual General Meeting of the Company.
13-05-2023
Bigul

Neogen Chemicals Ltd - 542665 - Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, May 13, 2023.

1. Approved the Audited Financial Results (Standalone and Consolidated) of the Company along with the Audit Reports for the Quarter and Financial Year ended March 31, 2023, pursuant to Regulation 33 of the Listing Regulations, which has been duly reviewed and recommended by the Audit Committee; Pursuant to Regulation 33(3) (d) of the Listing Regulations, we would like to declare that the Statutory Auditors of the Company M/s. JMT & Associates, Chartered Accountants (FRN: 104167W) have issued the Auditors Report on Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2023 with un-modified opinion and a declaration to that effect is enclosed.2. Recommended a final dividend of Rs. 3 per Equity Share for the Financial Year 2022-23, subject to approval of shareholders at the ensuing Annual General Meeting of the Company.
13-05-2023
Bigul

Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 (6) of the Listing Regulations, we would like to inform you that the Earnings Conference Call is scheduled to be held on Monday, May 15, 2023 at 5.00 p.m. IST for analysts and investors to discuss the Q4 & FY23 results, to be declared on Saturday, May 13, 2023.
10-05-2023
Bigul

Neogen Chemicals Ltd - 542665 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 (' Listing Regulations').

Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2023 ,inter alia, to consider and approve Pursuant to regulation 29 and 33 of the Listing Regulations, notice is hereby given that a meeting of the Board of Directors of the Company is schedule to be held on Saturday, May 13, 2023, inter-alia, to consider, approve and take on record the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended on March 31, 2023 and to consider recommendation of a final dividend, if any, on the equity shares of the Company, for the financial year ended March 31, 2023 subject to declaration and approval of the same by the shareholders at the ensuing Annual General Meeting.
06-05-2023
Bigul

Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Updates on Acquisition

With regards to the captioned subject and in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 ('Listing Regulations'), we wish to inform you that Neogen Chemicals Limited ('the Company') has acquired 4,69,26,000 (100%) Equity Shares of a face value of Rs. 10 each, of BuLi Chemicals India Private Limited ('BuLi Chem') from Livent USA Corporation (formerly known as FMC Lithium USA Corporation) and Livent Corporation (formerly known as FMC Lithium USA Holding Corporation) ('Selling Shareholders') for an amount of Rs. 19,35,46,833 (Rupees Nineteen Crore Thirty Five lakh Forty Six Thousand Eight Hundred and Thirty Three Only), pursuant to the working capital adjustments on the closing date i.e. May 3 2023 ('Acquisition') and the terms of the Share Purchase Agreement dated March 4, 2023 ('SPA'). Pursuant to the said transaction BuLi Chem has become a Wholly Owned Subsidiary of the Company.
03-05-2023
Bigul

Neogen Chemicals Ltd - 542665 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyNeogen Chemicals Ltd 2CIN NO.L24200MH1989PLC050919 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 158.89 4Highest Credit Rating during the previous FY A 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Unnati Kanani Designation: Company Secretary and Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Ketan Vyas Designation: Chief Financial Officer EmailId: [email protected] Date: 29/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
29-04-2023
Bigul

Neogen Chemicals Ltd - 542665 - Pursuant To Regulation 40 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015, We Are Enclosing Herewith The Certificate Issued To Neogen Chemicals Limited In Respect Of Aforesaid Regulation By DVD & Associates, Practicing Company Secretaries, Pune For The Financial Year Ended March 31, 2023.

Pursuant to Regulation 40 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we are enclosing herewith the certificate issued to Neogen Chemicals Limited in respect of aforesaid Regulation by DVD & Associates, Practicing Company Secretaries, Pune for the financial year ended March 31, 2023.
11-04-2023

Neogen Chemicals spurts 6% on pact with Japanese major for electrolyte solutions

The agreement will enable Neogen Chemicals to capitalize on the growing demand of lithium-ion batteries in India.
11-04-2023
Bigul

Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Investor Presentation

With reference to the captioned subject, please find enclosed herewith the Presentation with respect to signing of a landmark agreement with MU Ionic Solutions Corporation, Japan to acquire manufacturing technology license for electrolytes in India.
10-04-2023
Next Page
Close

Let's Open Free Demat Account